The purpose of this study is to learn about possible changes in thinking (cognitive) abilities, such as memory skills, and in brain anatomy and function, in adults with multiple myeloma who are treated with high-dose chemotherapy followed by ASCT.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
18
Patients will undergo structural and functional (rsfMRI) brain MRIs (total time= \~15 minutes) at enrollment (prior to HD-Chemo/ASCT) and approximately 3-4 months after ASCT.
Patients will undergo structural and functional (rsfMRI) brain MRIs (total time= \~15 minutes) at enrollment (prior to HD-Chemo/ASCT) and approximately 3-4 months after ASCT.
Evaluates auditory attention and working memory
Rutgers University - Data Analysis
New Brunswick, New Jersey, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Changes in neurocognitive functions in older participants with Multiple Myeloma following high-dose (HD) chemotherapy and autologous stem cell transplantation (ASCT) assessed by initial and follow-up neurocognitive evaluation
Time frame: up to 4 months following chemotherapy and ASCT
Changes in regional brain volume and functional connectivity when baseline and follow-up MRIs are compared.
Time frame: up to 4 months following chemotherapy and ASCT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assesses selective auditory attention
Assesses visual scanning, graphomotor speed, and setshifting
Assesses attention and susceptibility to interference
A timed test of verbal fluency.
The HVLT-R is a test of verbal learning and recall.
assesses perceived depression
A 13-item questionnaire designed to assess symptoms and concerns specific to the QOL of patients with fatigue
Blood samples will be collected at each time point (pre-ASCT; 3-4 months and post-ASCT) to assess serum levels of inflammatory cytokines.